Verition Fund Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-12,800
Closed -$227K – 793
2019
Q4
$227K Hold
12,800
– – ﹤0.01% 925
2019
Q3
$199K Buy
12,800
+100
+0.8% +$1.65K 0.01% 953
2019
Q2
$218K Buy
+12,700
New +$205K 0.01% 953

Other funds holding HALO

Verition Fund Management's HALO Position: Q2 2026 in Review

Verition Fund Management opened a new position in Halozyme (HALO) in Q2 2026: 12,500 shares worth $978K. The stake represents 0.01% of the portfolio and ranks #1423 among its holdings. This is a return to the name: Verition Fund Management previously reported a position in HALO as recently as Q4 2025.

Verition Fund Management first reported a position in HALO in Q2 2014 and has held it in 26 quarters since. The position peaked at $5M in Q3 2025. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Verition Fund Management held 12,500 shares of Halozyme worth $978K as of Q2 2026.
  • Halozyme was a new Verition Fund Management position in Q2 2026.
  • Halozyme made up 0.01% of Verition Fund Management's portfolio in Q2 2026, its #1423 holding.
  • Verition Fund Management first reported a position in Halozyme in Q2 2014 and has held it in 26 quarters since.
  • Verition Fund Management's Halozyme position peaked at $5M in Q3 2025.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.